Bis-huperzine B: Highly potent and selective acetylcholine sterase inhibitors

被引:54
作者
Feng, S [1 ]
Wang, ZF [1 ]
He, XC [1 ]
Zheng, SX [1 ]
Xia, Y [1 ]
Jiang, HL [1 ]
Tang, XC [1 ]
Bai, DL [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, State Key Lab Drug Res, Shanghai 201203, Peoples R China
关键词
D O I
10.1021/jm0496178
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
By targeting dual active sites of AChE, a series of bis-huperzine B analogues with various lengths of the tether were designed, synthesized, and tested for their inhibition and selectivity. The most potent bis-huperzine B (5g) exhibited 3900-fold increase in AChE inhibition and 930-fold greater in selectivity for AChE vs BuChE than its parent huperzine B.
引用
收藏
页码:655 / 657
页数:3
相关论文
共 21 条
[1]   Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease [J].
Bai, DL ;
Tang, XC ;
He, XC .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (03) :355-374
[2]  
Carlier PR, 2000, ANGEW CHEM INT EDIT, V39, P1775, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1775::AID-ANIE1775>3.0.CO
[3]  
2-Q
[4]   Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis [J].
Carlier, PR ;
Han, YF ;
Chow, ESH ;
Li, CPL ;
Wang, H ;
Lieu, TX ;
Wong, HS ;
Pang, YP .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (02) :351-357
[5]   Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities [J].
Cheng, DH ;
Tang, XC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (02) :377-386
[6]   X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-Huperzine A and (-)-huperzine B:: Structural evidence for an active site rearrangement [J].
Dvir, H ;
Jiang, HL ;
Wong, DM ;
Harel, M ;
Chetrit, M ;
He, XC ;
Jin, GY ;
Yu, GL ;
Tang, XC ;
Silman, I ;
Bai, DL ;
Sussman, JL .
BIOCHEMISTRY, 2002, 41 (35) :10810-10818
[7]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&
[8]  
Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO
[9]  
2-O
[10]  
HIEBLE JP, 1995, PRINCIPLES PHARM BAS, P145